-1750795215206.webp&w=3840&q=75)
2025 MLS Nashville | IV Iron Deficiency Anemia | IV Clinical and Practice Considerations
Overview
Dr. Walsh surveyed iron deficiency across cancer care—stressing recognition even without anemia, symptom clues, key labs, IV iron options, and urgent treatment in pregnancy—while linking untreated deficiency to poorer cardiovascular outcomes and highlighting novel agents such as luspatercept for polycythemia vera. Additional guidance on addressing iron deficiency with high ferritin levels and using capsule endoscopy to uncover small‑bowel bleeding was addressed.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Katherine Walsh, MD
Date of Release
June 25th, 2025
